These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35910645)

  • 1. Genetic Diversity and Low Therapeutic Impact of Variant-Specific Markers in HIV-1 Pol Proteins.
    Troyano-Hernáez P; Reinosa R; Holguín A
    Front Microbiol; 2022; 13():866705. PubMed ID: 35910645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV Capsid Protein Genetic Diversity Across HIV-1 Variants and Impact on New Capsid-Inhibitor Lenacapavir.
    Troyano-Hernáez P; Reinosa R; Holguín Á
    Front Microbiol; 2022; 13():854974. PubMed ID: 35495642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV Transmembrane Glycoprotein Conserved Domains and Genetic Markers Across HIV-1 and HIV-2 Variants.
    Valadés-Alcaraz A; Reinosa R; Holguín Á
    Front Microbiol; 2022; 13():855232. PubMed ID: 35694284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New findings in cleavage sites variability across groups, subtypes and recombinants of human immunodeficiency virus type 1.
    Torrecilla E; Llácer Delicado T; Holguín Á
    PLoS One; 2014; 9(2):e88099. PubMed ID: 24516589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: performance evaluation of the new REGA version 3 and seven other tools.
    Pineda-Peña AC; Faria NR; Imbrechts S; Libin P; Abecasis AB; Deforche K; Gómez-López A; Camacho RJ; de Oliveira T; Vandamme AM
    Infect Genet Evol; 2013 Oct; 19():337-48. PubMed ID: 23660484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High level of multidrug resistance mutations in HIV type 1 pol gene and resistance-associated mutations to enfuvirtide (T-20) among antiretroviral-experienced patients from central Brazil.
    Cardoso LP; Stefani MM
    AIDS Res Hum Retroviruses; 2009 Oct; 25(10):943-50. PubMed ID: 19792869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 Protease, Reverse Transcriptase, and Integrase Variation.
    Rhee SY; Sankaran K; Varghese V; Winters MA; Hurt CB; Eron JJ; Parkin N; Holmes SP; Holodniy M; Shafer RW
    J Virol; 2016 Jul; 90(13):6058-6070. PubMed ID: 27099321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.
    Yaotsè DA; Nicole V; Roch NF; Mireille PD; Eric D; Martine P
    Infect Genet Evol; 2009 Jul; 9(4):646-52. PubMed ID: 19460333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pol gene diversity of five human immunodeficiency virus type 1 subtypes: evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D.
    Cornelissen M; van den Burg R; Zorgdrager F; Lukashov V; Goudsmit J
    J Virol; 1997 Sep; 71(9):6348-58. PubMed ID: 9261352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global analysis of sequence diversity within HIV-1 subtypes across geographic regions.
    Huang A; Hogan JW; Istrail S; Delong A; Katzenstein DA; Kantor R
    Future Virol; 2012 May; 7(5):505-517. PubMed ID: 22822410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evolution of HIV-1 group M genetic variability in Southern Cameroon is characterized by several emerging recombinant forms of CRF02_AG and viruses with drug resistance mutations.
    Agyingi L; Mayr LM; Kinge T; Orock GE; Ngai J; Asaah B; Mpoame M; Hewlett I; Nyambi P
    J Med Virol; 2014 Mar; 86(3):385-93. PubMed ID: 24248638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in the HIV-1 gp41 env gene, natural resistance to enfuvirtide (T-20) and pol resistance among pregnant Brazilian women.
    Reis MN; de Alcântara KC; Cardoso LP; Stefani MM
    J Med Virol; 2014 Jan; 86(1):8-17. PubMed ID: 24037943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of reverse transcriptase and protease mutations associated with antiretroviral drug resistance among drug-naïve HIV-1 infected pregnant women in Kagera and Kilimanjaro regions, Tanzania.
    Nyombi BM; Holm-Hansen C; Kristiansen KI; Bjune G; Müller F
    AIDS Res Ther; 2008 Jun; 5():13. PubMed ID: 18570675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV type 1 pol gene diversity and archived nevirapine resistance mutation in pregnant women in Rwanda.
    Servais J; Lambert C; Karita E; Vanhove D; Fischer A; Baurith T; Schmit JC; Schneider F; Hemmer R; Arendt V
    AIDS Res Hum Retroviruses; 2004 Mar; 20(3):279-83. PubMed ID: 15117451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short Communication: Update in Natural Antiretroviral Resistance-Associated Mutations Among HIV Type 2 Variants and Discrepancies Across HIV Type 2 Resistance Interpretation Tools.
    Troyano-Hernáez P; Reinosa R; Burgos MC; Holguín Á
    AIDS Res Hum Retroviruses; 2021 Oct; 37(10):793-795. PubMed ID: 33586996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rev Protein Diversity in HIV-1 Group M Clades.
    Lebedev A; Kim K; Ozhmegova E; Antonova A; Kazennova E; Tumanov A; Kuznetsova A
    Viruses; 2024 May; 16(5):. PubMed ID: 38793640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel method for simultaneous quantification of phenotypic resistance to maturation, protease, reverse transcriptase, and integrase HIV inhibitors based on 3'Gag(p2/p7/p1/p6)/PR/RT/INT-recombinant viruses: a useful tool in the multitarget era of antiretroviral therapy.
    Weber J; Vazquez AC; Winner D; Rose JD; Wylie D; Rhea AM; Henry K; Pappas J; Wright A; Mohamed N; Gibson R; Rodriguez B; Soriano V; King K; Arts EJ; Olivo PD; Quiñones-Mateu ME
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3729-42. PubMed ID: 21628544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of new, emerging HIV-1 unique recombinant forms and drug resistant viruses circulating in Cameroon.
    Ragupathy V; Zhao J; Wood O; Tang S; Lee S; Nyambi P; Hewlett I
    Virol J; 2011 Apr; 8():185. PubMed ID: 21513545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral Imprints and Genomic Plasticity of HIV-1
    Bimela JS; Nanfack AJ; Yang P; Dai S; Kong XP; Torimiro JN; Duerr R
    Front Microbiol; 2021; 12():812391. PubMed ID: 35222310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep analysis of HIV-1 natural variability across HIV-1 variants at residues associated with integrase inhibitor (INI) resistance in INI-naive individuals.
    Llácer Delicado T; Torrecilla E; Holguín Á
    J Antimicrob Chemother; 2016 Feb; 71(2):362-6. PubMed ID: 26546669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.